Want to join the conversation?
Ross Muken of Evercore ISI asks about core revenue growth. $A said it is pleased with higher than guided core revenue growth achieved in 3Q16. The company is confident of achieving core growth guidance for 2016. $A intends to maintain the overall core revenue growth for the whole of 2016 without raising the guidance for 4Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?